Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules – A response

We read with interest the paper by Mari ño et al. which suggests an increased risk of hepatocellular carcinoma (HCC) in cirrhotic patients treated with direct-acting antivirals (DAAs), (3.7%/100 person-years [PY]) especially in those with undetermined nodules before treatment (9.6%/100 PY).1

Source: Journal of Hepatology - May 22, 2019 Category: Gastroenterology Authors: Stanislas Pol, H élène Fontaine, Fabrice Carrat, on the behalf of the ANRS/AFEF Hepather Study group Tags: Letter to the Editor Source Type: research